Maintenance azacitidine after myeloablative allogeneic hematopoietic cell transplantation for myeloid malignancies

  • Kathryn T. Maples, Roy T. Sabo, John M. McCarty, Amir A. Toor, Kelly G. Hawks
  • Leukemia & Lymphoma, April 2018, Taylor & Francis
  • DOI: 10.1080/10428194.2018.1443334

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/10428194.2018.1443334

The following have contributed to this page: Dr Amir Ahmed Toor and Kelly Hawks